Catalyst
Slingshot members are tracking this event:
Tesaro (TSRO) Plans to Finalize Potential Lung Cancer Registration Study and Initiate Development Program for Niraparib in 1H 2017
Do you think this event is important to the companies below? How will it affect their stock price?
| Related Companies | Importance
|
Impact on Stocks
|
||||
|---|---|---|---|---|---|---|
| TSRO |
|
|
||||
Slingshot Insights Explained
Catalyst Date
Occurred on:
Mar 27, 2017
Occurred Source:
http://ir.tesarobio.com/releasedetail.cfm?ReleaseID=1018917
Related Projects
-
Don’t see a project related to the catalyst you care about?
Related Keywords
Niraparib, Lung Cancer, Registration Study, Development Programs
